Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland

Journal of Endocrinology

Volumn 157, Issue 1, 1998, Pages 99-106

  Muccioli, G ^a   Ghe C ^a   Ghigo, M C ^a   Papotti, M ^a   Arvat, E ^b   Boghen, M F ^c   Nilsson, M H L ^c   Deghenghi, R ^d   Ong, H ^e   Ghigo, E ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c PFIZER INC   (United States)

^d Ardana   (France)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RECEPTOR;

ARTICLE; BINDING SITE; CHEMICAL MODIFICATION; CORPUS CALLOSUM; DRUG RECEPTOR BINDING; GROWTH HORMONE RELEASE; HORMONE ACTION; HUMAN; HUMAN TISSUE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MEMBRANE BINDING; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RADIOIODINATION; SCATCHARD PLOT;

EID: 17644439585     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1570099     Document Type: Article

References (48)

1. 2) in rat anterior pituitary cells. Endocrinology 132 1286-1291.
2. Arvat E, Gianotti L, Di Vito L, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F & Ghigo E 1995 Modulation of growth hormone-releasing activity of hexarelin in man. Neuroendocrinology 61 51-56.
3. Arvat E, Di Vito L, Maccagno B, Broglio F, Boghen MF, Deghenghi R, Camanni F & Ghigo E 1997 Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effect of GHRH, TRH and hCRH. Peptides 18 885-892.
4. Bitar KG, Bowers CY & Coy DH 1991 Effect of substance P/bombesin antagonists on the release of growth hormone by GHRP and GHRH. Biochemical and Biophysical Research Communications 180 156-161.
5. Bowers CY 1993 GH releasing peptides: structure and kinetics. Journal of Pediatric Endocrinology 6 21-31.
6. Bowers CY, Momany FA, Reynolds GA & Hong A 1984 On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114 1537-1545.
7. Bowers CY, Sartor AO, Reynolds GA & Badger TM 1991 On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 128 2027-2035.
8. Chang CH, Rickes EL, Marsilio F, McGuire L, Cosgrove S, Taylor J, Chen H, Fleighner S, Clark JN, De Vita R, Schoen W, Wyvratt M Jr, Fisher M, Smith RG & Hickey GJ 1995 Activity of a novel nonpeptidyl growth hormone secretagogue, L-700,653, in swine. Endocrinology 136 1065-1071.
9. Cheng K, Chan W-WS, Butler B, Wei L, Schoen WR, Wyvratt MJ, Fisher MH & Smith RG 1993 Stimulation of growth hormone release from rat pituitary cells by L-692,429, a novel nonpeptidyl GH secretagogue. Endocrinology 132 2729-2731.
10. Cheng K, Wei L, Chaung L-Y, Chan W-WS, Butler B, Pong S-S & Smith RG 1994 Substance P antagonist inhibits L-693,429 and GHRP6-stimulated rat growth hormone release both in vitro and in vivo. Program of the 76th Meeting of the Endocrine Society, Anaheim, CA, p 366.
11. Codd EE, Yellin T & Walker RF 1988 Binding of growth hormone releasing hormones and enkephalin-derived growth hormone-releasing peptides to mu and delta opioid receptors in forebrain of rat. Neuropharmacology 27 1019-1025.
12. Codd EE, Shu AYL & Walker RF 1989 Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology 28 1129-1144.
13. Conley LK, Teik JA, Deghenghi R, Imbimbo BP, Giustina A, Locatelli V & Vehrenberg WB 1995 Mechanism of action of hexarelin and GHRP6: analysis of the involvement of GHRH and somatostatin in the rat. Neuroendocrinology 61 44-50.
14. Deghenghi R, Cananzi M M, Torsello A, Battisti C, Müller E E & Locatelli V 1994 GH releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult rats. Life Sciences 54 1321-1328.
15. Dickson SL & Luckman SM 1997 Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 138 771-777.
16. Dickson SL, Doutrelant-Viltart O & Leng G 1995 GH-deficient dw/dw rats and lit/lit mice show increased Fos expression in the hypothalamic arcuate nucleus following systemic injection of GH releasing peptide-6. Journal of Endocrinology 146 519-528.
17. Dickson SL, Doutrelant-Viltart O, Dyball LRE & Leng G 1996 Retrogradely labelled neurosecretory neurones of the rat hypothalamic arcuate nucleus express Fos protein following systemic injection of GH-releasing peptide-6. Journal of Endocrinology 151 323-331.
18. Fairhall KM, Mynett A & Robinson ICAF 1995 Central effects of growth hormone-releasing hexapeptide (GHRP6) on growth hormone release are inhibited by central somatostatin action. Journal of Endocrinology 144 555-560.
19. Fletcher TP, Thomas GB, Willoughby JO & Clarke IJ 1994 Constitutive growth hormone secretion in sheep after hypothalamo-pituitary disconnection and the direct in vivo pituitary effect of growth hormone releasing peptide-6. Neuroendocrinology 60 76-86.
20. Frieboes R-M, Murck H, Maier P, Schier T, Holsboer F & Steiger A 1995 Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and Cortisol in man. Neuroendocrinology 61 584-589.
21. Furchgott RF 1978 Pharmacological characterization of receptors: its relation to radioligand binding studies. Federation Proceedings 37 115-120.
22. Gertz BJ, Bonett JS, Eisenhandler R, Drupa DA, Wittreich JM, Seibold JR & Schneider SH 1993 Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. Journal of Clinical Endocrinology and Metabolism 77 1393-1397.
23. Ghigo E, Arvat E, Gianotti L, Imbimbo BP, Lenaerts V, Deghenghi R & Camanni F 1994 Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. Journal of Clinical Endocrinology and Metabolism 78 693-698.
24. Ghigo E, Arvat E, Muccioli G & Camanni F 1997 Growth hormone-releasing peptides. European Journal of Endocrinology 136 445-460.
25. Hickey GJ, Drisko J, Faidley T, Cheng C, Anderson LL, Nicolich S, McGuire L, Rickes E, Krupa D, Feeney W, Friscino B, Cuningham P, Frazier F, Chen H, Laroque P & Smith RG 1996 Mediation by central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585. Journal of Endocrinology 148 371-380.
26. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosemblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KL, Pong S-S, Chaung L-Y, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Shaeffer JM, Smith RG & Van der Ploeg LHT 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 974-977.
27. Jacks T, Hickey G, Judith F, Taylor J, Chen H, Krupa D, Feeney W, Schoen W, Ok D, Fisher M, Wyvratt MJ & Smith RG 1994 Effect of acute and repeated intravenous administration of L-692,585, a novel nonpeptidyl growth hormone secretagogue, on plasma growth hormone, IGF-I, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles. Journal of Endocrinology 143 399-406.
28. Korbonits M & Grossman AB 1995 Growth hormone-releasing peptide and its analogues. Novel stimuli to growth hormone release. Trends in Endocrinology and Metabolism 6 43-49.
29. Lei T, Buchfelder M, Fahlbusch R & Adams EF 1995 Growth hormone releasing peptide (GHRP6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotroph cells. Journal of Molecular Endocrinology 14 135-138.
30. Locke W, Kirgis HD, Bowers CY & Abdoh AA 1995 Intracerebroventricular growth hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in rats. Life Sciences 55 1347-1352.
31. Lowry OH, Rosebrough NL, Farr AL & Randall RJ 1951 Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 265-275.
32. Momany FA, Bowers CY, Reynolds GA, Hong A & Newlander K 1981 Design, synthesis and biological activity of peptides which release growth hormone in vitro. Endocrinology 108 31-39.
33. Müller EE &: Nisticò G 1989 Brain Messengers and the Pituitary, San Diego, CA: Academic Press.
34. Nieuwenhuys R, Voogd J & van Huijzen CHA 1981 The Human Central Nervous System, edn 2. New York: Springer-Verlag.
35. Ong H, McNicoll N, Escher E, Collu R, Deghenghi R, Locatlli V, Ghigo E, Muccioli G, Boghen M & Nilsson M 1998 Identification of a pituitary GHRP receptor subtype by the photoaffinity labeling approach. Endocrinology 139 432-435.
36. Pardridge WM 1986 Receptor-mediated peptide transport through the blood-brain barrier. Endocrine Reviews 7 314-330.
37. Patchett AA, Nargund RP, Tata JR, Chen M-H, Barakat KJ, Johnston DBR, Cheung K, Chan W-WS, Butler B, Hichey G, Jacks T, Schleim K, Pong S-S, Chaung L-Y P, Chen HY, Frazier E, Leung KH, Chiu S-HL & Smith RG 1995 Design and biological activities of L-163,191 (MK 0677): a potent orally active growth hormone-secretagogue. Proceedings of the National Academy of Sciences of the USA 92 7001-7005.
38. Pomès A, Pong S-S & Schaeffer JM 1996 Solubilization and characterization of a growth hormone secretagogue receptor from porcine anterior pituitary membranes. Biochemical and Biophysical Research Communications 225 939-945.
39. Pong S-S, Chaung L-YP, Dean DC, Nargund RP, Patchett A A & Smith RG 1996 Identification of a new G-protein-linked receptor for growth hormone-secretagogues. Molecular Endocrinology 10 57-61.
40. Reichert LE Jr 1988 Characterization of membrane receptors: some general considerations. In Hormones and their Actions, Part I, pp 105-116. Eds BA Cooke, RJB King & HJ Van der Molen. Amsterdam: Elsevier Science Publishers B V (Biomedical Division).
41. Renner U, Brockmeier S, Strasburger CJ, Lange M, Schopohl J, Muller OA, Werder K & Stalla GK 1994 Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interactions with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide. Journal of Clinical Endocrinology and Metabolism 78 1090-1096.
42. Scatchard G 1949 The attraction of proteins for small molecules and ions. Annals of the New York Academy of Sciences 51 660-672.
43. Sethumadavan K, Veeraragavan K & Bowers CY 1991 Demonstration and characterization of the specific binding of growth hormone-releasing peptide to rat anterior pituitary and hypothalamic membranes. Biochemical and Biophysical Research Communications 178 31-37.
44. Sirinathsinghji DJS, Chen HY, Hopkins R, Trumbauer M, Heavens R, Rigby M, Smith RG & Van der Ploeg LHT 1995 Induction of c-fos mRNA in the arcuate nucleus of normal and mutant growth hormone-deficient mice by a synthetic non-peptidyl growth hormone secretagogue. Molecular Neuroscience 6 1989-1992.
45. Smith RG, Cheng K, Schoen WR, Pong S-S, Hickey G, Jacks T, Butler B, Chan WW, Chaung L-YP, Judith F, Taylor J, Wyvratt MJ & Fisher MH 1993 A nonpeptidyl growth hormone secretagogue. Science 260 1640-1643.
46. Steel RGD & Torrie JH 1960 Principles and Procedures of Statistics. New York: McGraw-Hill.
47. Veeraragavan K, Sethumadavan K & Bowers CY 1992 Growth hormone-releasing peptide (GHRP) binding to porcine anterior pituitary and hypothalamic membranes. Life Sciences 50 1149-1155.
48. Wu D, Chen C, Zhang J, Katoh K & Clark I 1994 Effects in vitro of new growth hormone releasing peptide (GHRP1) on growth hormone secretion from ovine pituitary cells in primary culture. Journal of Neuroendocrinology 6 185-190.